By Robert Herriman @infectiousdiseasenews
Lyme disease. So much we seem not to know, in many different areas.
Draft guidelines for the diagnosis and treatment of Lyme disease were recently issued by the Infectious Disease Society of America (IDSA)–two really big, contentious issues.
And of course there are the disagreements of how the various organizations view these Lyme topics–I’ve often termed this the establishment vs. the advocates.
My guest today took a look at this in a recent two-part series in Forbes entitled “Lyme Wars”.
Joining me is the author and infectious disease physician, Judy Stone, MD.
The Lyme Wars: Major Organizations Aren’t Playing Nicely Together
The Lyme Wars, Part 2: Which Way Should We Treat?
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Stitcher | RSS
Other interviews with Dr Stone:
Lassa fever: An interview with Dr Judy Stone
Vibrio vulnificus: An interview with Dr Judy Stone
mcr-1 gene: An interview with Dr Judy Stone
Crimean-Congo Hemorrhagic Fever: A conversation with Dr Judy Stone
Other Lyme disease interviews:
Lyme and other tickborne diseases: ‘We need a national public-private strategy’
Lyme testing with Monica Embers, PhD
Lyme disease: New study confirms dogs are sentinels to assess human risk
3 thoughts on “Lyme disease: The major players, the disagreements and the IDSA draft guidelines”
The main.weapon.against Lyme is the same as for aids. Prevention,knowledge,system wide education.